Clorox (NYSE:CLX – Get Free Report) issued an update on its FY 2027 earnings guidance on Tuesday. The company provided EPS guidance of 5.700-6.000 for the period, compared to the consensus earnings per share estimate of 5.690. The company issued revenue guidance of $7.6 billion-$7.7 billion, compared to the consensus revenue estimate of $7.6 billion.
Clorox Trading Up 5.7%
Shares of NYSE CLX opened at $99.12 on Thursday. The company’s 50 day simple moving average is $87.88 and its 200 day simple moving average is $99.77. Clorox has a fifty-two week low of $79.12 and a fifty-two week high of $128.90. The firm has a market capitalization of $11.99 billion, a P/E ratio of 17.83, a P/E/G ratio of 3.09 and a beta of 0.59. The company has a debt-to-equity ratio of 32.91, a current ratio of 0.65 and a quick ratio of 0.38.
Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Monday, November 2nd. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.48. Clorox had a net margin of 9.41% and a return on equity of 608.30%. The firm had revenue of $1.91 billion during the quarter, compared to analyst estimates of $1.88 billion. During the same quarter in the previous year, the business earned $0.85 EPS. The business’s quarterly revenue was up 33.3% compared to the same quarter last year. On average, analysts predict that Clorox will post 5.75 EPS for the current year.
Clorox Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 5.0%. The ex-dividend date is Wednesday, October 28th. Clorox’s payout ratio is presently 89.93%.
Wall Street Analysts Forecast Growth
Several research firms have weighed in on CLX. BNP Paribas Exane decreased their target price on Clorox from $97.00 to $95.00 and set a “neutral” rating for the company in a research note on Monday, July 20th. Wall Street Zen downgraded Clorox from a “hold” rating to a “sell” rating in a report on Saturday, October 3rd. Citigroup cut their price objective on Clorox from $97.00 to $90.00 and set a “neutral” rating on the stock in a report on Wednesday, October 14th. UBS Group set a $88.00 target price on Clorox in a research note on Tuesday. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $95.00 price target on shares of Clorox in a research note on Monday, October 19th. One investment analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, Clorox has an average rating of “Reduce” and a consensus price target of $93.79.
Get Our Latest Stock Report on CLX
Key Headlines Impacting Clorox
Here are the key news stories impacting Clorox this week:
- Positive Sentiment: Clorox beat first-quarter earnings and revenue estimates, with higher sales, cost savings and contributions from GOJO supporting results. It maintained fiscal 2027 adjusted EPS guidance of $5.70–$6.00 and revenue guidance of $7.6 billion–$7.7 billion. Clorox Q1 Earnings Beat Estimates on Higher Sales & Cost Savings
- Neutral Sentiment: Analyst views are mixed. Morgan Stanley raised its target to $94 but kept an equal-weight rating; UBS raised its target to $96 and maintained neutral, while Barclays reiterated a sell rating. Morgan Stanley rating and price target
- Negative Sentiment: Inflation and other rising costs are squeezing margins, and reports indicate Clorox expects earnings nearer the low end of its forecast. That could limit the benefit of the quarterly beat. Q1 Earnings Call Highlights Inflation and Margin Pressures
- Negative Sentiment: Investors also face concerns about dividend coverage and increased debt following the GOJO acquisition, while management’s comments about consumer spending point to a potentially challenging economic backdrop. Clorox Earnings Outlook and Dividend Concerns
About Clorox
The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.
Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.
Read More
- Five stocks we like better than Clorox
- Keurig Dr Pepper’s Beverage Growth Raises a Tough Question About Its Coffee Split
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
